| Akaber Halawi, MD | |
|
653 W 8th St, Jacksonville, FL 32209-6511 | |
| (904) 244-3498 | |
| Not Available |
| Full Name | Akaber Halawi |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 18 Years |
| Location | 653 W 8th St, Jacksonville, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255610648 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 35.122974 (Ohio) | Secondary |
| 207Y00000X | Otolaryngology | R-9101 (Iowa) | Secondary |
| 207Y00000X | Otolaryngology | ME130483 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Union Memorial Hospital | Baltimore, MD | Hospital |
| Sinai Hospital Of Baltimore | Baltimore, MD | Hospital |
| Medstar Good Samaritan Hospital | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Maryland Ent Center Llc | 4486712155 | 3 |
News Archive
A study of fibromyalgia patients highlights the impact of sleep symptoms on health-related quality of life in this population.
Takeda Pharmaceutical Company Limited today announced the initiation of an international phase 3 clinical trial evaluating once a week MLN9708 in combination with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma who are not candidates for transplant.
After looking at the health records of over 10,000 patients with both HIV and multidrug resistant Tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Centers for Disease Control and Prevention, McGill University, and other institutions around the world, found that implementing antiretroviral therapy (ART) for HIV and newer tuberculosis medications decreased the risk of death for adults with drug-resistant TB.
InSite Vision Incorporated, a company developing ophthalmic products for unmet eye care needs, today announced plans to advance new development candidate ISV-303, a topical anti-inflammatory product intended to reduce the pain and swelling associated with ocular surgery.
Corthera Inc. has announced that results from Pre-RELAX-AHF, the Phase II portion of a Phase II/III multicenter, randomized, double-blind, placebo-controlled international study, demonstrated promising efficacy and safety for relaxin, the company's investigational drug for treatment of acute heart failure (AHF).
› Verified 2 days ago
| Entity Name | Maryland Ent Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689690513 PECOS PAC ID: 4486712155 Enrollment ID: O20081023000878 |
News Archive
A study of fibromyalgia patients highlights the impact of sleep symptoms on health-related quality of life in this population.
Takeda Pharmaceutical Company Limited today announced the initiation of an international phase 3 clinical trial evaluating once a week MLN9708 in combination with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma who are not candidates for transplant.
After looking at the health records of over 10,000 patients with both HIV and multidrug resistant Tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Centers for Disease Control and Prevention, McGill University, and other institutions around the world, found that implementing antiretroviral therapy (ART) for HIV and newer tuberculosis medications decreased the risk of death for adults with drug-resistant TB.
InSite Vision Incorporated, a company developing ophthalmic products for unmet eye care needs, today announced plans to advance new development candidate ISV-303, a topical anti-inflammatory product intended to reduce the pain and swelling associated with ocular surgery.
Corthera Inc. has announced that results from Pre-RELAX-AHF, the Phase II portion of a Phase II/III multicenter, randomized, double-blind, placebo-controlled international study, demonstrated promising efficacy and safety for relaxin, the company's investigational drug for treatment of acute heart failure (AHF).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Akaber Halawi, MD Po Box 44008, Jacksonville, FL 32231-4008 Ph: (904) 244-3498 | Akaber Halawi, MD 653 W 8th St, Jacksonville, FL 32209-6511 Ph: (904) 244-3498 |
News Archive
A study of fibromyalgia patients highlights the impact of sleep symptoms on health-related quality of life in this population.
Takeda Pharmaceutical Company Limited today announced the initiation of an international phase 3 clinical trial evaluating once a week MLN9708 in combination with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma who are not candidates for transplant.
After looking at the health records of over 10,000 patients with both HIV and multidrug resistant Tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Centers for Disease Control and Prevention, McGill University, and other institutions around the world, found that implementing antiretroviral therapy (ART) for HIV and newer tuberculosis medications decreased the risk of death for adults with drug-resistant TB.
InSite Vision Incorporated, a company developing ophthalmic products for unmet eye care needs, today announced plans to advance new development candidate ISV-303, a topical anti-inflammatory product intended to reduce the pain and swelling associated with ocular surgery.
Corthera Inc. has announced that results from Pre-RELAX-AHF, the Phase II portion of a Phase II/III multicenter, randomized, double-blind, placebo-controlled international study, demonstrated promising efficacy and safety for relaxin, the company's investigational drug for treatment of acute heart failure (AHF).
› Verified 2 days ago
Dr. Alexander A Farag, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 836 Prudential Dr Ste 1601, Jacksonville, FL 32207 Phone: 904-396-8060 Fax: 904-390-7385 | |
Dr. Erin Rae Spadaro Hamersley, D.O. Otolaryngology Medicare: Medicare Enrolled Practice Location: 554 Keily Street, Jacksonville, FL 32212 Phone: 757-953-7550 Fax: 757-953-7560 | |
Charvar Jones, Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 532 Riverside Ave, Jacksonville, FL 32202 Phone: 904-791-6632 | |
Robert C Sprecher, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 807 Childrens Way, Nemours Childrens Clinic, Jacksonville, Jacksonville, FL 32207 Phone: 904-697-3694 Fax: 904-697-3927 | |
Samip Patel, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4500 San Pablo Rd S, Jacksonville, FL 32224 Phone: 904-953-2000 | |
Jeffrey Paul Radabaugh, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 836 Prudential Dr Ste 1601, Jacksonville, FL 32207 Phone: 904-396-8060 Fax: 904-390-7385 | |
Cheyenne Roohani, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 807 Childrens Way, Jacksonville, FL 32207 Phone: 904-697-3600 Fax: 904-687-3927 |